NO970946L - Blanding for å hindre smerte inneholdende et ikke-narkotisk analgetikum og en analgesi forsterker - Google Patents

Blanding for å hindre smerte inneholdende et ikke-narkotisk analgetikum og en analgesi forsterker

Info

Publication number
NO970946L
NO970946L NO970946A NO970946A NO970946L NO 970946 L NO970946 L NO 970946L NO 970946 A NO970946 A NO 970946A NO 970946 A NO970946 A NO 970946A NO 970946 L NO970946 L NO 970946L
Authority
NO
Norway
Prior art keywords
mixture
narcotic analgesic
prevent pain
enhancer
pain containing
Prior art date
Application number
NO970946A
Other languages
English (en)
Norwegian (no)
Other versions
NO970946D0 (no
Inventor
David J Mayer
Donald D Price
Jianren Mao
John W Lyle
Original Assignee
Univ Virginia Commonwealth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Virginia Commonwealth filed Critical Univ Virginia Commonwealth
Publication of NO970946D0 publication Critical patent/NO970946D0/no
Publication of NO970946L publication Critical patent/NO970946L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Polymerisation Methods In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO970946A 1994-09-02 1997-02-28 Blanding for å hindre smerte inneholdende et ikke-narkotisk analgetikum og en analgesi forsterker NO970946L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30073694A 1994-09-02 1994-09-02
US38206395A 1995-02-01 1995-02-01
PCT/US1995/010994 WO1996007412A1 (en) 1994-09-02 1995-08-29 Composition alleviating pain, containing a non-narcotic analgesic and an analgesia enhancer

Publications (2)

Publication Number Publication Date
NO970946D0 NO970946D0 (no) 1997-02-28
NO970946L true NO970946L (no) 1997-04-28

Family

ID=26971951

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970946A NO970946L (no) 1994-09-02 1997-02-28 Blanding for å hindre smerte inneholdende et ikke-narkotisk analgetikum og en analgesi forsterker

Country Status (20)

Country Link
EP (1) EP0778770B1 (de)
JP (1) JPH10505087A (de)
KR (1) KR970705390A (de)
CN (1) CN1213753C (de)
AT (1) ATE255895T1 (de)
AU (1) AU714653B2 (de)
BR (1) BR9508671A (de)
CA (1) CA2197463A1 (de)
CZ (1) CZ60697A3 (de)
DE (1) DE69532285T2 (de)
ES (1) ES2211916T3 (de)
FI (1) FI970865A7 (de)
HU (1) HUT76798A (de)
MX (1) MX9701477A (de)
NO (1) NO970946L (de)
NZ (1) NZ292429A (de)
PL (1) PL319029A1 (de)
RU (1) RU2003115093A (de)
TW (1) TW449474B (de)
WO (1) WO1996007412A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840731A (en) * 1995-08-02 1998-11-24 Virginia Commonwealth University Pain-alleviating drug composition and method for alleviating pain
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
CA2250042A1 (en) * 1996-03-25 1997-10-02 Eli Lilly And Company Treating pain using a synergistic combination of an atypical antipsychotic and a drug used in treatment of pain
AU7472798A (en) * 1997-05-07 1998-11-27 Algos Pharmaceutical Corporation Cox-2 inhibitors in combination with nmda-blockers for treating pain
AU8107998A (en) * 1997-05-22 1998-12-11 Boots Company Plc, The Pharmaceutical compositions
AU8668598A (en) 1997-08-20 1999-03-08 University Of Oklahoma, The Gaba analogs to prevent and treat gastrointestinal damage
WO1999012537A1 (en) 1997-09-08 1999-03-18 Warner-Lambert Company Analgesic compositions comprising anti-epileptic compounds and methods of using same
WO1999036064A2 (en) * 1998-01-13 1999-07-22 Synchroneuron, Llc Methods of treating tardive dyskinesia and other movement disorders
US6054451A (en) * 1998-04-21 2000-04-25 Algos Pharmaceutical Corporation Analgesic composition and method for alleviating pain
EP1146905A1 (de) * 1998-11-12 2001-10-24 Algos Pharmaceutical Corporation Cox-2 hemmstoffe in kombination mit nmda-blockern zur behandlung von schmerzen
EP1603548A4 (de) * 2003-02-05 2007-10-10 Myriad Genetics Inc Verfahren und zusammensetzung zur behandlung neurodegenerativer erkrankungen
DE102010024559A1 (de) 2010-06-22 2011-12-22 Süd-Chemie AG Verfahren zur Herstellung hydrophober Oberflächen
CN102266563A (zh) * 2011-07-13 2011-12-07 赵磊 一种复方止痛组合物及其制备方法
JP7673337B2 (ja) * 2019-11-07 2025-05-09 アリナミン製薬株式会社 医薬組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4339428A (en) * 1980-08-18 1982-07-13 Bristol-Myers Company Capsule product containing high dosage of aspirin in powder or granulated form and alkaline tablet or pellet comprising magnesium carbonate, calcium carbonate and a magnesium dry component
CA1194799A (en) * 1981-12-10 1985-10-08 Eric L. Nelson Method and composition for reducing menstrual pain
US4446140A (en) * 1981-12-10 1984-05-01 Nelson Research & Development Company Method and composition for treating mouth pain
AU2062892A (en) * 1991-08-16 1993-02-18 Mcneil-Ppc, Inc. Potentiation of antitussive effect of dextromethorphan

Also Published As

Publication number Publication date
ATE255895T1 (de) 2003-12-15
BR9508671A (pt) 1998-01-06
ES2211916T3 (es) 2004-07-16
NZ292429A (en) 2000-01-28
FI970865L (fi) 1997-03-14
HUT76798A (en) 1997-11-28
AU3460495A (en) 1996-03-27
CN1213753C (zh) 2005-08-10
FI970865A7 (fi) 1997-03-14
MX9701477A (es) 1998-02-28
DE69532285D1 (de) 2004-01-22
DE69532285T2 (de) 2004-09-23
KR970705390A (ko) 1997-10-09
JPH10505087A (ja) 1998-05-19
FI970865A0 (fi) 1997-02-28
TW449474B (en) 2001-08-11
NO970946D0 (no) 1997-02-28
CZ60697A3 (cs) 1998-02-18
RU2003115093A (ru) 2004-12-10
WO1996007412A1 (en) 1996-03-14
CA2197463A1 (en) 1996-03-14
CN1158085A (zh) 1997-08-27
EP0778770A1 (de) 1997-06-18
PL319029A1 (en) 1997-07-21
EP0778770B1 (de) 2003-12-10
HK1006108A1 (en) 1999-02-12
AU714653B2 (en) 2000-01-06

Similar Documents

Publication Publication Date Title
AU4078897A (en) Anticonvulsant containing composition for treating neuropathic pain
EP0938305B8 (de) Verfahren zur erleichterung von schmerzen durch eine kombination von tramadol und einen nmda-antagonist
AU3984597A (en) Formulation of 5-ht agonists
ATE260646T1 (de) Schnell zerfallende orale dosierungsform
AU1537095A (en) Therapeutic agents containing thyroid hormones
NO954582D0 (no) Blanding for nasal administrering av nikotin
NZ333385A (en) Solid oral dosage forms containing 35% of valsartan
CL2003002785A1 (es) Uso de 4,5,6,7-tetrahidroisoxazolo(5,4-c)piridin-3-ol (thip) para preparar una composicion farmaceutica util para tratar un trastorno del sueno.
NO20053105D0 (no) Oral, analgesisk doseringsform med forlenget frigivelse for administrering ±n gang pr. dag.
MXPA02007690A (es) Composiciones de liberacion controlada que contienen agonista y antiagonista de opioide.
FI972542A0 (fi) Transdermaalijärjestelmä useamman aktiivisen aineen samanaikaista antamista varten
NO970946D0 (no) Blanding for å hindre smerte inneholdende et ikke-narkotisk analgetikum og en analgesi forsterker
SI1572167T1 (sl) Transdermalni buprenorfinski dozirni reĹľim za analgezijo
AU4130196A (en) Methods of treating migraine
Lipton et al. Influence of propranolol, phenoxybenzamine or phentolamine on the in vivo nocturnal rise of pineal melatonin levels in the Syrian hamster
HK95697A (en) 5-HT1-like receptor agonist for rectal administration
TNSN98049A1 (fr) Composition pharmaceutique a residence gastrique.
CA2154455A1 (en) Analgesic composition
PT706395E (pt) Uso de ropivacaina na preparacao duma composicao farmaceutica com efeito analgesico e bloqueio motor minimo
EP1051994A3 (de) 5HT1-Rezeptor-Agonisten und COX-2 Inhibitoren zur Behandlung von Migräne
PT1030659E (pt) Composicao farmaceutica compreendendo efedrina-(+) antagonista do receptor h1.
Wallenborn et al. Safety of metoclopramide in PONV prophylaxis using doses higher than 10mg intraoperatively: 9AP6-9

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application